Jodi D. Bradley

1.2k total citations
11 papers, 588 citations indexed

About

Jodi D. Bradley is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jodi D. Bradley has authored 11 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Jodi D. Bradley's work include Fibroblast Growth Factor Research (2 papers), Platelet Disorders and Treatments (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). Jodi D. Bradley is often cited by papers focused on Fibroblast Growth Factor Research (2 papers), Platelet Disorders and Treatments (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). Jodi D. Bradley collaborates with scholars based in United States, Sweden and Germany. Jodi D. Bradley's co-authors include William P. Sisk, Diana Wetmore, Drew E. Van Dyk, Robert A. Horlick, Michael W. Pantoliano, Timothy W. Tobery, James D. Lear, Barry A. Springer, Chi‐How Peng and Roselyn J. Eisenberg and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Jodi D. Bradley

10 papers receiving 569 citations

Peers

Countries citing papers authored by Jodi D. Bradley

Since Specialization

Citations

This map shows the geographic impact of Jodi D. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi D. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi D. Bradley more than expected).

Fields of papers citing papers by Jodi D. Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi D. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi D. Bradley. The network helps show where Jodi D. Bradley may publish in the future.

Co-authorship network of co-authors of Jodi D. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi D. Bradley. A scholar is included among the top collaborators of Jodi D. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi D. Bradley. Jodi D. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Abstract P2-13-09: An investigational next generation ADC (DAN-311) is highly effective in HER2-low breast cancer models 2022 ·Cancer Research ·Ashley P. Wright, (unknown), (unknown), (unknown), Jodi D. Bradley, (unknown), (unknown)	0
2	Efficacy of DAN-222, a novel investigational polymeric nanoparticle with topoisomerase I inhibitor, as monotherapy in breast cancer models and when combined with PARP inhibitor. 2021 ·Journal of Clinical Oncology ·Ashley P. Wright, Jodi D. Bradley, (unknown), (unknown)	3
3	Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist 2003 ·Platelets ·Dietmar Seiffert, (unknown), Jodi D. Bradley, (unknown), (unknown), David M. Kornhauser, Valerie A. Cain, (unknown), Giora Feuerstein, David E. Martin, Andrew M. Stern	3
4	Mutations at the P1′ position of Notch1 decrease intracellular domain stability rather than cleavage by γ-secretase 2002 ·Biochemical and Biophysical Research Communications ·Yuval Blat, Jere E. Meredith, Qian Wang, Jodi D. Bradley, Lorin A. Thompson, Richard E. Olson, Andrew M. Stern, Dietmar Seiffert	13
5	Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated 2002 ·Blood ·Jeffrey T. Billheimer, Ira B. Dicker, Richard Wynn, Jodi D. Bradley, Debra Cromley, Helen E. Godonis, (unknown), (unknown), (unknown), Donna L. Pedicord, Susan Spitz, (unknown), Nina Zolotarjova, (unknown), Gregory Hollis, Robert Daly, Andrew M. Stern, Dietmar Seiffert	47
6	Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. 1999 ·PubMed ·Jodi D. Bradley, Yuki Kataoka, Sunil J. Advani, (unknown), Ramin B. Arani, G. Yancey Gillespie, R. J. Whitley, James M. Markert, Bernard Roizman, Ralph R. Weichselbaum	74
7	Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization 1994 ·Biochemistry ·Michael W. Pantoliano, Robert A. Horlick, Barry A. Springer, Drew E. Van Dyk, Timothy W. Tobery, Diana Wetmore, James D. Lear, (unknown), Jodi D. Bradley, William P. Sisk	219
8	High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells 1994 ·Journal of Virology ·William P. Sisk, Jodi D. Bradley, (unknown), (unknown), Manuel Ponce de Leon, (unknown), Chi‐How Peng, Gary H. Cohen, Roselyn J. Eisenberg	102
9	Deletion of hydrophobic domains of viral glycoproteins increases the level of their production in Escherichia coli 1992 ·Gene ·William P. Sisk, Jodi D. Bradley, David M. Kingsley, Thomas A. Patterson	14
10	Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A. 1989 ·The Journal of Cell Biology ·Jean‐Jacques Feige, Jodi D. Bradley, (unknown), James Farris, (unknown), (unknown), Andrew Baird	41
11	Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae. 1988 ·Journal of Biological Chemistry ·P J Barr, Lawrence S. Cousens, (unknown), Angelica Medina-Selby, Frank R. Masiarz, Robert A. Hallewell, Scott Chamberlain, Jodi D. Bradley, (unknown), Kathelyn S. Steimer	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact